1. Home
  2. GILD vs CMCSA Comparison

GILD vs CMCSA Comparison

Compare GILD & CMCSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GILD
  • CMCSA
  • Stock Information
  • Founded
  • GILD 1987
  • CMCSA 1963
  • Country
  • GILD United States
  • CMCSA United States
  • Employees
  • GILD N/A
  • CMCSA N/A
  • Industry
  • GILD Biotechnology: Biological Products (No Diagnostic Substances)
  • CMCSA Cable & Other Pay Television Services
  • Sector
  • GILD Health Care
  • CMCSA Telecommunications
  • Exchange
  • GILD Nasdaq
  • CMCSA Nasdaq
  • Market Cap
  • GILD 138.7B
  • CMCSA 131.5B
  • IPO Year
  • GILD 1992
  • CMCSA 1972
  • Fundamental
  • Price
  • GILD $110.17
  • CMCSA $35.23
  • Analyst Decision
  • GILD Buy
  • CMCSA Buy
  • Analyst Count
  • GILD 24
  • CMCSA 21
  • Target Price
  • GILD $110.95
  • CMCSA $43.10
  • AVG Volume (30 Days)
  • GILD 6.3M
  • CMCSA 17.7M
  • Earning Date
  • GILD 08-07-2025
  • CMCSA 07-31-2025
  • Dividend Yield
  • GILD 2.87%
  • CMCSA 3.74%
  • EPS Growth
  • GILD 1118.07
  • CMCSA 7.84
  • EPS
  • GILD 4.73
  • CMCSA 4.07
  • Revenue
  • GILD $28,735,000,000.00
  • CMCSA $123,560,000,000.00
  • Revenue This Year
  • GILD $1.69
  • CMCSA $1.95
  • Revenue Next Year
  • GILD $3.67
  • CMCSA $3.00
  • P/E Ratio
  • GILD $23.29
  • CMCSA $8.68
  • Revenue Growth
  • GILD 4.68
  • CMCSA 1.33
  • 52 Week Low
  • GILD $70.78
  • CMCSA $31.44
  • 52 Week High
  • GILD $119.96
  • CMCSA $45.31
  • Technical
  • Relative Strength Index (RSI)
  • GILD 51.17
  • CMCSA 53.18
  • Support Level
  • GILD $107.75
  • CMCSA $35.37
  • Resistance Level
  • GILD $110.90
  • CMCSA $35.02
  • Average True Range (ATR)
  • GILD 2.31
  • CMCSA 0.61
  • MACD
  • GILD -0.38
  • CMCSA -0.07
  • Stochastic Oscillator
  • GILD 33.99
  • CMCSA 54.72

About GILD Gilead Sciences Inc.

Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of newer combination regimens that remain standards of care. Gilead is also growing its presence in the oncology market via acquisitions, led by CAR-T cell therapy Yescarta/Tecartus (from Kite) and breast and bladder cancer therapy Trodelvy (from Immunomedics).

About CMCSA Comcast Corporation

Comcast is made up of three parts. The core cable business owns networks capable of providing television, internet access, and phone services to 64 million US homes and businesses, or nearly half of the country. About 50% of the locations in this territory subscribe to at least one Comcast service. Comcast acquired NBCUniversal from General Electric in 2011. NBCU owns several cable networks, including CNBC, MSNBC, and USA, the NBC network, the Peacock streaming platform, several local NBC affiliates, Universal Studios, and several theme parks. The firm plans to spin off most of its cable networks later in 2025. Finally, Sky, acquired in 2018, is a large television provider in the UK and Italy, and it also has a presence in Germany and Austria.

Share on Social Networks: